NCT03587025 is a Phase 3 clinical trial of Amitriptyline in Pain, Postoperative, sponsored by University of Campinas, Brazil.

Who is sponsoring NCT03587025?

NCT03587025 is sponsored by University of Campinas, Brazil.

What drugs are being tested in NCT03587025?

Interventions in NCT03587025: Amitriptyline, Placebo.

What condition does NCT03587025 study?

NCT03587025 studies Pain, Postoperative.

Is NCT03587025 still recruiting?

NCT03587025 is currently completed. Last updated 26 November 2018.

Last reviewed 2018-11-26 · How we verify

NCT03587025

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Preemptive Analgesia With Amitryptyline for Prevention of Pain in Women After Hysterectomy

Completed Phase 3 Last updated 26 November 2018

What this trial tests

Phase 3 trial testing Amitriptyline in Pain, Postoperative in 150 participants. Completed in 30 October 2018.

Timeline

1 June 2015

Primary endpoint
30 October 2018

30 October 2018

Quick facts

Lead sponsor	University of Campinas, Brazil
Phase	Phase 3
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	prevention
Enrollment	150
Start date	1 June 2015
Primary completion	30 October 2018
Estimated completion	30 October 2018
Sites	1 location across Brazil

Drugs / interventions tested

Amitriptyline (AMITRIPTYLINE) — full drug profile →
Placebo

Conditions studied

Pain, Postoperative — all drugs for Pain, Postoperative →

Sponsor

University of Campinas, Brazil

Who can join

Adults 18 to 60, female only, with Pain, Postoperative. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine whether amitryptyline is effective in the prevention of pain in women after a total abdominal hysterectomy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Amitriptyline

Trials testing the same drug.

NCT06245564 — Effect of Ketamine, Amitriptyline and Their Combination on Itch · NA · completed
NCT06417684 — Comparison of Amitriptyline to Lifestyle Modification as Intervention for Vestibular Migraine · EARLY_PHASE1 · withdrawn
NCT06312813 — Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With · Phase 2 · recruiting
NCT06162819 — Efficacy of Flunarizine Vs Amitriptyline in Prophylaxis of Migraine Prophylaxis · NA · unknown
NCT05889624 — Responding With Evidence and Access for Childhood Headaches · NA · recruiting

Other recruiting trials for Pain, Postoperative

Currently open trials in the same condition.

NCT07512141 — Single Versus Double Drains in the Axillary and Pectoral Regions After Modified Radical Mastectomy · NA · recruiting
NCT07354581 — Erector Spinae Plane Block vs Quadro-Iliac Plane Block After Lumbar Instrumentation Surgery · NA · recruiting
NCT07239817 — PENG Block + LIA For Endoprosthesis Surgery With Anterior Approach · NA · recruiting
NCT06740214 — Analgesic Efficacy of Different Liposomal Bupivacaine Doses in the Adductor Canal Block for Total Knee Arthroplasty · Phase 3 · recruiting
NCT07057557 — Aloe Vera vs Paraffin Tulle Dressings for Pain Management in Split Thickness Skin Graft Donor Sites · NA · recruiting

Other University of Campinas, Brazil trials

Trials by the same sponsor.

NCT06929676 — Assessment of Tooth Mobility After Non-surgical Periodontal Treatment Followed by Tooth Splinting · NA · enrolling by invitation
NCT07456163 — Influence of Zirconia Abutments on Peri-Implant Tissues in Single-Tooth Restorations · NA · recruiting
NCT06884475 — Evaluation of Implantoplasty in the Treatment of Peri-Implantitis. · NA · active not recruiting
NCT06450327 — Resistant Hypertension An Open, Complicated ("Cum Plicare") or Complex ("Cum Plexus") Syndrome? · recruiting
NCT06600867 — Method for Measuring Dental Mobility and Displacement Force · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03587025 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Campinas, Brazil
Last refreshed: 26 November 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03587025.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing